There are actually separate care pathways for sufferers with a class A and course B CPS and for sufferers with a category C CPS. Also, the authors give an algorithmic method of these agents during the transplant population, focusing on 1st line use of glucagon-like peptide 1 (GLP-one) agonists https://glp-1-semaglutide15825.ampblogs.com/stdie-patch-options-73491764